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OBJECTIVES We sought to determine whether intrinsic mitochondrial function and regulation were altered
in heart transplant recipients (HTRs) and to investigate the response of mitochondrial
function to six-week endurance training in these patients.
BACKGROUND Despite the normalization of central oxygen transport during exercise, HTRs are still
characterized by limited exercise capacity, which is thought to result from skeletal muscle
metabolic abnormalities.
METHODS Twenty HTRs agreed to have vastus lateralis biopsies and exercise testing: before and after
training for 12 of them and before and after the same control period for eight subjects
unwilling to train. Mitochondrial respiration was evaluated on saponin-permeabilized muscle
fibers in the absence or presence (maximum respiration rate [Vmax]) of saturating adenosine
diphosphate.
RESULTS Mitochondrial function was preserved at the level of sedentary subjects in untrained HTRs,
although they showed 28  5% functional aerobic impairment (FAI). After training, Vmax,
citrate synthase, cytochrome c oxidase, and mitochondrial creatine kinase (CK) activities were
significantly increased by 48%, 40%, 67%, and 53%, respectively (p  0.05), whereas FAI
decreased to 12  5% (p  0.01). The control of mitochondrial respiration by creatine and
mitochondrial CK was also improved (p  0.01), suggesting that phosphocreatine synthesis
and transfer by the mitochondrial CK become coupled to oxidative phosphorylation, as shown
in trained, healthy subjects.
CONCLUSIONS In HTRs, the mitochondrial properties of skeletal muscle were preserved and responded well
to training, reaching values of physically active, healthy subjects. This suggests that, in HTRs,
immunosuppressive drugs do not alter the intrinsic muscle oxidative capacities and that the
patients’ physical handicap results from nonmitochondrial mechanisms. (J Am Coll Cardiol
2003;42:126–32) © 2003 by the American College of Cardiology Foundation
Heart transplantation is the ultimate therapy for patients
with end-stage congestive heart failure (CHF) and results in
normalization of resting and exercise hemodynamics, im-
provement of tissue perfusion, and disappearance of the
deleterious neurohormonal disorders that accompany CHF
(1). However, despite the normalization of central oxygen
transport during exercise (2), heart transplant recipients
(HTRs) are still characterized by a limited exercise capacity
at the New York Heart Association (NYHA) functional
class II level. The reasons for this remain only partially
understood, but most authors point out skeletal muscle
metabolic abnormalities as the major cause (3,4). Indeed, an
increased phosphocreatine breakdown for a given work rate
and a decreased adenosine triphosphate (ATP) resynthesis
rate have been observed in these patients (3). Moreover,
skeletal muscle alterations observed in HTRs include low
oxidative enzyme activities, an altered fiber type composi-
tion, and a reduced capillary network, as compared with
healthy subjects (5,6). These skeletal muscle abnormalities
are thought to result from detraining, persisting heart failure
abnormalities, and/or deleterious effects of immunosuppres-
sive drugs (3,4,6,7). In rat skeletal muscle, long-term
administration of immunosuppressive treatment with high
cyclosporin A (CsA) doses decreases oxidative capacity of
skeletal muscle (8–10), suggesting that a direct and/or
indirect deleterious effect of antirejection therapy might
alter the skeletal muscle mitochondrial function in vivo in
HTR patients (6). However, we have shown that this effect
is due to the vehicle rather than to the active molecule
(10,11). We have previously observed a normal mitochon-
drial volume density in the skeletal muscle of HTRs, but
without the correlation with peak oxygen consumption
(VO2) usually observed in healthy subjects (6), suggesting
that mitochondria could be quantitatively normal but func-
tionally altered in the skeletal muscle of these patients, a
hypothesis consistent with a drug effect. However, the
actual intrinsic mitochondrial function and regulation have
never been determined in HTRs.
On the other hand, as deconditioning may represent a
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major factor of physical handicap after transplantation,
numerous studies have addressed the effects of short- and
long-term endurance training in HTRs (12–14) and have
shown beneficial increases of exercise capacity (12,15).
Using ultrastructural morphometry, we observed that short-
term endurance training was able to improve the total and
subsarcolemmal mitochondrial volume density within the
skeletal muscle but did not change the already reduced
capillary network (7). Although we and others have recently
shown that endurance training induces enhancement of
both muscle oxidative capacity and mechanisms of respira-
tory control in skeletal muscles of healthy subjects (16–18),
the response of mitochondrial function to endurance train-
ing needs to be determined in HTRs. As we have demon-
strated that HTRs’ exercise capacity after training remained
lower than that of untrained, normal, sedentary subjects (7),
the response to training of the skeletal muscle mitochondrial
function could be altered in HTRs. Therefore, in an effort
to sort out the contribution of intrinsic mitochondrial
properties to exercise limitation in HTRs under standard
immunosuppressive treatment, we assessed the skeletal
muscle oxidative capacity and its regulation and investigated
the adaptation of mitochondrial function to a six-week
endurance training program. To this end, mitochondrial
respiration was studied in situ by a method recently adapted
to human samples (16,18,19), that is based on selective
permeabilization of the sarcolemma, keeping mitochondria
in their intracellular environment (20).
METHODS
Subjects. Twenty-three HTRs (19 men and 4 women)
were enrolled in the study. All subjects gave their written,
informed consent to the study, which was approved by the
local institutional ethics committee. The HTRs were free of
significant rejection or infection and were enrolled in the
training program 9  1 month after grafting. Before
surgery, our patients were in NYHA class III or IV. As part
of their immunosuppressive regimen they received oral CsA
(Neoral, Novartis, Basel, Switzerland; 252  19 mg/day)
and prednisone (18  4 mg/day). Some patients were
treated with antihypertensive therapy, calcium channel
blockers, and furosemide. Beyond the three-week standard
immediate postoperative rehabilitation, none of them were
enrolled in any regular physical training program but re-
sumed their professional or private activities at the time of
the study. All patients were in NYHA class I or II at the
time of enrollment. Three patients had to be withdrawn
from the study: one for acute rejection that resolved but
temporarily prevented the patient from exercising; one for
mild rhabdomyolysis; and one for sciatic nerve syndrome.
Of the remaining 20 patients, 12 completed a supervised
six-week endurance training program (T group), whereas
the other eight untrained subjects (UT group) did not wish
to engage in any form of physical training and were
considered as control subjects for spontaneous changes.
Experimental design. MAXIMUM EXERCISE TESTING. Pa-
tients underwent a graded maximum exercise test in the
upright position, using an electronically braked bicycle
ergometer. Throughout exercise, expired gas analysis was
performed using a breath-by-breath metabolic cart that
yielded oxygen consumption (VO2) and the ventilatory
threshold (VT) by V-slope analysis (21). The work load was
increased by 20 W every 2 min until volitional exhaustion,
to yield the maximum tolerated power (MTP) and peak
VO2. In patients undergoing training, lactate microsamples
were taken at the earlobe at the end of exercise and every
minute during the first 5 min of passive recovery, with the
maximum recorded lactate value being defined as peak
lactate. In the T group after training, a lactate sample was
taken when the step at the pretraining maximum work rate
was completed. The functional aerobic impairment (FAI)
was calculated as follows: FAI  ([predicted peak VO2 
observed peak VO2]/predicted peak VO2)  100, used to
evaluate the limited exercise capacity of HTRs (4). Pre-
dicted peak VO2 was calculated using Hansen’s formulae
(21).
TRAINING PROTOCOL. Training included three 45-min
sessions per week for six weeks of modified interval training,
as previously described (7). Each session consisted of nine
successive 5-min bouts. During each exercise bout, a 4-min
moderate base work load was followed by 1 min of heavy
peak level work load. Bases and peaks were initially set at
the individual VT and at 90% of MTP, respectively. Target
work rates were adjusted to maintain the exercise heart rate
during training at base and peak levels reached during the
first session.
SKELETAL MUSCLE BIOPSY. Vastus lateralis muscle was ob-
tained by the Bergstro¨m biopsy technique under local
anesthesia. One part was immediately frozen in liquid
nitrogen for enzymatic and myosin heavy chain (MyHC)
studies. Thin bundles were immediately dissected in iced-
cold relaxing solution containing (in mmol/l) 10 EGTA-
calcium buffer (free Ca2 concentration, 100 nmol/l), 1 free
Mg2, 20 taurine, 0.5 dithiothreitol, 20 imidazole (pH 7.1),
5 MgATP, and 15 phosphocreatine, at 160 ionic strength
Abbreviations and Acronyms
ADP  adenosine diphosphate
CHF  congestive heart failure
CK  creatine kinase
CsA  cyclosporin A
FAI  functional aerobic impairment
HTRs  heart transplant recipients
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MyHC  myosin heavy chain
T  trained subjects
UT  untrained subjects
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VO2  oxygen consumption
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(potassium methanesulfonate) and permeabilized for 30 min
with 50 g/ml saponin for respiration studies.
MITOCHONDRIAL RESPIRATION, BIOCHEMICAL STUDIES,
AND MYOSIN DETERMINATION. Oxidative capacity and mi-
tochondrial regulation of vastus lateralis muscle fibers were
studied in situ in freshly saponin-skinned fibers, as previ-
ously described (22,23). Briefly, respiratory rates were de-
termined with a Clark electrode (Strathkelvin Instruments,
Glasgow, U.K.) in the presence of 2 mmol/l adenosine
diphosphate (ADP) and normalized to fiber dry weight.
The ADP-stimulated respiration (VADP) above basal VO2
was plotted as a function of ADP. The apparent Michaelis-
Menten constant (Km) for ADP, inversely proportional to
ADP sensitivity, and VADP were calculated using a nonlin-
ear fitting of the Michaelis-Menten equation. The maxi-
mum respiration rate (Vmax) is expressed as: VADP  basal
VO2. It characterizes the oxidative capacity of the muscle.
Citrate synthase, cytochrome c oxidase, creatine kinase
(CK), and lactate dehydrogenase activities were assessed by
standard spectrophotometric methods. Lactate dehydroge-
nase and CK isoenzymes were separated using 1% agarose
gel electrophoresis, as described (23,24). Isoforms of
MyHC were separated by sodium dodecyl sulfate/
polyacrylamide gel electrophoresis (25).
Statistical analysis. Data are expressed as the mean value
 SEM. The effect of training or the spontaneous evolution
in the untrained group was assessed by means of two-way
analysis of variance for repeated measures (one-factor rep-
etition), whereas differences between groups were analyzed
using the unpaired Student t test. The level of significance
was set at p  0.05.
RESULTS
Subject characteristics and exercise testing. Age, weight,
and height were similar between the UT and T groups of
HTRs (Table 1). Table 2 shows the parameters of aerobic
performance during the incremental exercise test. The
calculated FAI was 24  5% in trained patients before
training and 28  6% in untrained patients initially. After
training, peak VO2 (18%, p  0.01), VO2 at VT (20%,
p  0.05), and MTP values (19%, p  0.01) were all
increased in the trained group. Therefore, the FAI de-
creased to only 12  5% (p  0.01). Lactate peak values
were identical before and after training (Table 2), whereas
the blood lactate concentration at the work load corre-
sponding to pretraining MTP was reduced after training (p
 0.01). There were no changes in any of these parameters
of aerobic performance during the same follow-up period in
the UT group.
Mitochondrial function. Although basal respiration re-
mained identical in both the T and UT groups and was not
significantly changed by training or over time, Vmax was
markedly increased by training (from 4.8 0.8 to 7.1 0.8
mol O2/min per g dry weight; p  0.05) and approached
the values we previously observed in athletic, normal sub-
jects (7.9  0.5 mol O2/min per g dry weight), indicating
increased oxidative capacity by training. Maximum respira-
tion remained unchanged in the UT group over time and
was similar to pretraining values of the T group. As can be
seen in Figure 1B, the acceptor control ratio (Vmax/basal
VO2), a parameter representing the degree of coupling
between oxidation and phosphorylation, did not signifi-
cantly increase after training (3.9 0.6 vs. 4.4 0.5 [before
vs. after training]). Moreover, before and after training,
Vmax was not significantly correlated with peak VO2 (r 
0.38 vs. 0.23, respectively; p  0.1), suggesting that, unlike
in healthy subjects (17), the maximum exercise capacity is
not linked to the intrinsic oxidative capacity of the muscle in
HTRs. The apparent Km values for ADP in each group are
presented in Figure 2. In the absence of creatine, Km for
ADP remained stable over time in the UT group, whereas
it markedly increased after training (from 190  61 to 540
 105 mol/l, p 0.01), becoming similar to the values we
Table 1. Group Characteristics of Heart Transplant Recipients
Heart Transplant Recipients
Untrained Group Trained Group
Men/women 7/1 10/2
Age (yrs) 53.5  3.3 54.5  3.2
Weight (kg) 70.6  5.2 77.6  3.1
Height (cm) 166.0  1.5 173.0  2.5
Data are presented as the mean value  SEM.
Table 2. Effect of Training on the Incremental Maximal Exercise Test of HTR
HTR Untrained Group HTR Trained Group
Before After Before After
Peak VO2 (ml/min per kg) 23.1  3.0 23.6  3.0 22.0  2.0 26.0  2.3*
FAI (%) 27.9  6.2 20.8  6.8 24.4  4.6 12.1  5.0*
VT VO2 (ml/min per kg) 13.9  1.6 13.8  2.2 13.7  0.9 16.5  1.2†
MTP (W) 117  13 123  13 134  14 159  17*
Peak lactate concentration
(mmol/l)
— — 7.6  0.6 7.9  0.6
Lactate level at pretraining
MTP (mmol/l)
— — 6.1  0.5 4.6  0.6*
*p  0.01, †p  0.05 versus before training. Data are presented as the mean value  SEM
FAI  functional aerobic impairment; MTP  maximum tolerated power; VO2  oxygen uptake (standard temperature
pressure dry); VT  ventilatory threshold.
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already observed in athletic, normal subjects (563  92
mol/l) (17). The addition of creatine had no effect on Km
in the UT group, whereas mitochondrial CK activation was
followed by a dramatic drop in Km (from 540  105 to 148
 49 mol/l, p  0.01) after training. This near fourfold
decrease in the apparent Km values for ADP is the expres-
sion of an increase in ADP sensitivity and indicates a very
efficient mitochondrial CK coupling with oxidative
phosphorylation.
Enzymes activities and MyHC distribution. Activities of
citrate synthase and cytochrome c oxidase significantly
increased after training by 40% and 67%, respectively (p 
0.05). Total CK and CK-MM isoenzyme activities were
unaffected, whereas mitochondrial CK and MB-CK activ-
ities significantly increased after training by 53% and 57%,
respectively (p  0.05). Total lactate dehydrogenase activity
increased only over time in the UT group, whereas the
specific activity of its H subunit increased by 46% (p 0.05)
after training. The distribution of MyHC isoforms re-
mained identical after training. As can be seen in Table 3,
there were no spontaneous changes in all enzyme activities
and in the percentage of MyHC isoforms during the same
follow-up period in the UT group.
DISCUSSION
Major findings. This study, aimed at assessing the intrinsic
mitochondrial properties of skeletal muscle before and after
short-term endurance training in HTRs, showed, for the
first time, that mitochondrial respiration and the energy
Figure 1. Parameters of mitochondrial respiration. Muscle fiber bundles were taken from the vastus lateralis of heart transplant recipients before and after
training in the trained (T) group and at the same follow-up period in the untrained (UT) group. (A) Basal and maximum respiration (Vmax) (expressed in
mol O2/min per g dry weight) were measured in saponin-skinned fibers. (B) The acceptor control ratio (ACR) (Vmax/basal VO2). Data are expressed as
the mean value  SEM. *p  0.05 vs. T before training.
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transfer system quantitatively and qualitatively responded to
physical training, up to values previously measured in
healthy, trained subjects (16,17). However, unlike mito-
chondrial oxidative properties, the patients’ overall exercise
capacity still remained below the level expected in normal,
sedentary subjects similarly trained, suggesting that the
limitation of aerobic metabolism during exercise lies up-
stream from the mitochondrial machinery in HTRs. Be-
cause these mitochondrial properties are already normal
initially and respond normally to training in HTRs, mito-
chondrial toxicity due to immunosuppressive drugs is un-
likely in the clinical field, at least within the first year after
transplantation.
Mitochondrial function in untrained HTRs. After heart
transplantation, the persistence of an increased phosphocre-
atine breakdown for a given work rate and decreased
high-energy phosphate resynthesis rates, which even tends
to further worsen early after transplantation, raised the
question of impaired mitochondrial function after trans-
plantation (3). However, earlier we found no difference in
the ultrastructural mitochondrial volume density of the
vastus lateralis muscle between untrained HTRs and sed-
Figure 2. Apparent Michaelis-Menten constant (Km) for adenosine diphosphate (ADP)-stimulated respiration in the absence or presence of creatine. The
Km (mol/l) without creatine was increased after training (**p  0.01). The addition of creatine significantly decreased the Km, but only after training (§§p
 0.01 vs. Km without creatine). Dotted bars  untrained (UT) group before training; bars with diagonal lines  UT group after training; open bars
 trained (T) group before training; solid bars  T group after training.
Table 3. Effect of Training on Enzyme Activities and MyHC Distribution in HTRs
HTR Untrained Group HTR Trained Group
Before After Before After
Citrate synthase 14.4  2.2 15.1  0.7 14.6  1.4 20.5  1.5*
Cytochrome c oxidase 6.0  1.3 9.4  1.7 8.5  2.5 14.2  2.0*
Creatine kinase
Total CK 1,911  278 2,021  128 1,696  100 2,166  176
CK-MM 1,887  274 1,992  127 1,672  98 2,130  173
CK-MB 11.4  2.0 14.5  1.4 12.0  1.4 18.7  1.5*
mi-CK 12.2  2.5 14.6  1.4 11.4  1.5 17.3  1.5*
Adenylate kinase 350  43 383  30 291  25 366  29
LDH activity
Total LDH 146.5  28.5 213.0  28.3* 84.9  12.0 113.0  10.6
LDH-H 37.2  5.9 58.0  8.2 28.9  3.6 42.3  3.6*
LDH-M 109.3  23.8 154.9  23.1 56.0  9.0 70.8  7.8
H/M 0.45  0.08 0.44  0.07 0.59  0.06 0.67  0.06
MyHC (%)
MyHC-1 38.3  5.4 39.6  1.7 37.0  5.7 38.5  6.5
MyHC-2A 44.8  4.6 41.2  2.6 50.7  5.4 43.4  4.5
MyHC-2X 16.9  2.9 19.2  2.1 13.0  2.1 18.3  4.0
*p  0.05 versus before. Enzymatic activities are in IU/g wet weight. Data are presented as the mean value  SEM.
HTR  heart transplant recipients; CK  creatine kinase; LDH  lactate dehydrogenase: H and M  H and M
subunits. (H subunit  H4  3⁄4H3M  1⁄2H2M2  1⁄4HM3 and M subunit  M4  3⁄44H1M3
 1⁄22H2M2  1⁄4H3M, where H4, M4, H3M, H2M2, and HM3 are homo- and hetero-tetramers of LDH); mi 
mitochondrial; MyHC  myosin heavy chain.
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entary, healthy subjects (26). The present results extend
these data by showing that the muscle’s mitochondrial
function and regulation are preserved in HTRs and were
maintained similar to that of sedentary, healthy subjects
(16,17). This is also consistent with preserved intrinsic
mitochondrial function in CHF patients before transplan-
tation (16).
Mitochondrial function of trained HTRs. Because the
persisting physical handicap after transplantation is partly
due to deconditioning and because CsA, the major immu-
nosuppressive drug given in HTRs, has been shown in
animal studies to induce phenotypic changes and to atten-
uate the normal responses to muscular growth by inhibiting
the nuclear factor of activated T cells pathway (27,28), the
question of whether mitochondrial properties adequately
respond to training is of clinical relevance. We report here
that in HTRs, short-term endurance training markedly
increases the muscle’s oxidative capacity and enzyme activ-
ities, reaching values found in trained, healthy subjects
whose peak VO2 is twice as high (16). In normal subjects,
Walsh et al. (18) obtained 20% and 38% increases in peak
VO2 and Vmax, respectively, as a result of six-week training
by 60-min sessions at 70% of peak VO2, whereas in HTRs,
we observed 17% and 48% increases of peak VO2 and Vmax,
respectively, as a result of the same training duration with
45-min sessions but with an interval training protocol.
Thus, we obtained similar increases in exercise capacity and
higher increases in Vmax in HTRs, despite shorter session
durations. This is consistent with the well-known higher
beneficial effects of training in the most detrained subjects
for any given intensity (29). In addition, the regulation of
mitochondrial respiration also greatly responded to training.
As previously described (30), mitochondrial sensitivity to
ADP is characteristic of the metabolic phenotype of muscle,
being high in oxidative muscles (300 to 600 mol/l) and low
in glycolytic muscles (10 to 50 mol/l). Indeed, there was a
decrease in the mitochondrial sensitivity to ADP toward
values already found in trained, healthy subjects (16).
Moreover, this sensibility of mitochondria to ADP signifi-
cantly increased in the presence of creatine only after
training, suggesting an efficient mitochondrial CK coupling
with oxidative phosphorylation and the appearance of cou-
pled energy transfer pathways through the CK shuttle.
Thus, the present results suggest that as in athletic, normal
subjects (17), the mitochondrial CK system is likely to play
an important role in the control of mitochondrial respiration
in the skeletal muscle of trained HTRs. This allows the
connection between energy production by oxidative phos-
phorylation and energy utilization through cytosolic CK and
CK bound to myofilaments or the sarcoplasmic reticulum.
This servo-control of energy production by mitochondria
appears adapted for sustained contractile activity of endur-
ance exercise (17). On the other hand, the acceptor control
ratio was not significantly increased in trained HTRs, as was
the case in athletic subjects compared with sedentary sub-
jects, suggesting that long-term training is probably neces-
sary to significantly improve mitochondrial efficiency (17).
The same holds true for MyHC composition. It is possible
that neither the duration nor the intensity of the exercise
performed by our patients after transplantation was suffi-
cient to produce significant MyHC changes, because adap-
tive myosin changes to endurance training are known to be
late and inconsistent (31).
Clinical implications. The present study shows, for the
first time, that skeletal muscle fibers of HTR patients
exhibit a normal mitochondrial profile and normal expected
responses to physical training, despite immunosuppressive
therapy with CsA. Administration of CsA at high dosages
decreases mitochondrial respiration in vitro (8,11) and in
vivo (9,10) and alters the MyHC and metabolic profile of
animal skeletal muscle (28). As we demonstrated that these
muscular deleterious effects are due to the vehicle and not to
the active molecule (10,11), it is likely that at the clinical
doses of oral CsA, the toxic effects of the vehicle on
mitochondrial function are not detectable in humans. Be-
cause the beneficial changes of training on mitochondrial
function only partially translated into an increase in exercise
capacity, the mechanisms of limitation likely take place
upstream from the mitochondria and may further operate
after training. Among these mechanisms, a limited oxygen
and substrate delivery resulting from the reduced capillary
network, which remained unchanged after training (6,7),
might contribute to limit maximum exercise performance.
In addition, chronotropic incompetence due to graft dener-
vation contributes to build up a greater oxygen deficit for a
given work rate (32), rather than impairing the maximum
exercise heart rate (33). Moreover, the beneficial effects of
training on endothelial function might be offset by immu-
nosuppressive treatment (34,35). Indeed, CsA has been
shown to decrease endothelium-dependent vasodilation,
which might decrease oxygen delivery to mitochondria at
the microvascular level (34). On the other hand, develop-
ment of muscle atrophy is a well-known complication of
therapy with glucocorticoids. Horber et al. (36) showed that
prednisone at a mean dose of 10 mg/day was associated with
a decreased number of capillaries and fibers of the thigh
muscle but did not abrogate the exercise-induced improve-
ment of skeletal muscle in renal transplant patients. Indeed,
Renlund et al. (37) found that the corticosteroid dose
predicted exercise duration and peak VO2 in HTRs. Our
patients were treated with prednisone (18 4 mg/day), and
it cannot be completely ruled out that this treatment might
have induced muscle atrophy, contributing to limit their
exercise capacity, even though in a previous report (7), we
did not find any significant change in the thigh muscle area
in a similar population of patients.
Conclusions. In HTRs, the skeletal muscle mitochondrial
function is normal nine months after grafting and dramat-
ically improves after short-term endurance training, with
the emergence of an efficient coupling of mitochondrial CK
with ADP rephosphorylation. Thus, our data suggest, for
the first time, that: 1) the mitochondrial toxicity of immu-
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nosuppressive therapy, especially CsA, is negligible in the
clinical field and does not alter mitochondrial response to
training, at least within the first year after transplantation;
and 2) the mechanisms leading to the persisting physical
handicap after heart transplantation is independent of mus-
cular intrinsic metabolic capacities but proceeds from mech-
anisms upstream from the mitochondria, even more so after
training.
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